Co-Diagnostics Shares Jump After Advancement of Ebola PCR Assay Program
Co-Diagnostics Inc. (NASDAQ: CODX) saw its stock surge after announcing progress on PCR assay development targeting the Bundibugyo ebolavirus. The company said its Indian joint venture, CoSara Diagnostics, will support a joint development approach to enable potential regional manufacturing and faster deployment in select international markets, pend…